Published in J Antimicrob Chemother on January 01, 1997
Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother (2002) 7.73
AmpC beta-lactamases. Clin Microbiol Rev (2009) 7.14
Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob Agents Chemother (2000) 4.12
Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother (1998) 3.17
Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol (2005) 2.46
Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment. Clin Microbiol Rev (2004) 2.26
Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying blaKPC-2, blaDHA-1, qnrB4, and armA. Antimicrob Agents Chemother (2010) 1.91
Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob Agents Chemother (2006) 1.51
Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Chemother (2000) 1.50
β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev (2013) 1.45
First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test. J Clin Microbiol (2006) 1.44
Beta-lactamase nomenclature. Antimicrob Agents Chemother (2006) 1.41
Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production. Antimicrob Agents Chemother (2003) 1.34
Molecular epidemiology and characterization of plasmid-encoded beta-lactamases produced by Tunisian clinical isolates of Salmonella enterica serotype Mbandaka resistant to broad-spectrum cephalosporins. J Clin Microbiol (2003) 1.26
CFE-1, a novel plasmid-encoded AmpC beta-lactamase with an ampR gene originating from Citrobacter freundii. Antimicrob Agents Chemother (2004) 1.18
Multidrug and broad-spectrum cephalosporin resistance among Salmonella enterica serotype enteritidis clinical isolates in southern Italy. J Clin Microbiol (2002) 1.14
Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome. Antimicrob Agents Chemother (2001) 1.12
The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. Eur J Clin Microbiol Infect Dis (2008) 1.11
Biochemical and molecular characterization of three new variants of AmpC beta-lactamases from Morganella morganii. Antimicrob Agents Chemother (2006) 1.01
Multiple outbreaks of nosocomial salmonellosis in Russia and Belarus caused by a single clone of Salmonella enterica serovar Typhimurium producing an extended-spectrum beta-lactamase. Antimicrob Agents Chemother (2004) 0.98
Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- and DHA-1-type AmpC beta-lactamases in Korean respiratory isolates of Klebsiella pneumoniae. J Korean Med Sci (2005) 0.97
Expanded-spectrum cephalosporin-resistant salmonella strains in Romania. J Clin Microbiol (2002) 0.96
First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum beta-lactamase and DHA-1-type AmpC beta-lactamase at a Korean hospital. Yonsei Med J (2008) 0.94
First report of Salmonella isolates with the DHA-1 AmpC beta-lactamase in the United Kingdom. Antimicrob Agents Chemother (2004) 0.88
Antibiotic Resistance in Salmonella enterica Serovar Typhimurium Associates with CRISPR Sequence Type. Antimicrob Agents Chemother (2013) 0.85
Characterization of a DHA-1-producing Klebsiella pneumoniae strain involved in an outbreak and role of the AmpR regulator in virulence. Antimicrob Agents Chemother (2011) 0.79
Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics. Microorganisms (2015) 0.75
Occurrence of bla DHA-1 mediated cephalosporin resistance in Escherichia coli and their transcriptional response against cephalosporin stress: a report from India. Ann Clin Microbiol Antimicrob (2017) 0.75
Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis (1988) 17.69
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet (1987) 5.45
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2004) 5.09
Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother (2004) 3.87
Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother (1998) 3.17
Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother (1989) 2.93
A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother (2000) 2.85
Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis (1988) 2.71
Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol (1994) 2.66
Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiol Lett (1995) 2.63
Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxydans by DNA restriction fragment length polymorphism. J Clin Microbiol (1994) 2.60
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett (2000) 2.57
Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. J Clin Microbiol (1993) 2.51
Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2. Antimicrob Agents Chemother (1996) 2.48
Identification of additional virulence determinants on the pYV plasmid of Yersinia enterocolitica W227. Infect Immun (1989) 2.41
A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol Lett (1997) 2.40
In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. J Infect Dis (1989) 2.27
A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol (1996) 2.21
Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother (1990) 2.20
Construction by polymerase chain reaction and use of intragenic DNA probes for three main types of transferable beta-lactamases (TEM, SHV, CARB) [corrected]. FEMS Microbiol Lett (1991) 2.15
Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol (1998) 2.10
Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett (1998) 2.09
Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors. J Antimicrob Chemother (1992) 2.04
Evaluation of tuberculosis transmission in a community by 1 year of systematic typing of Mycobacterium tuberculosis clinical isolates. J Clin Microbiol (1996) 2.03
Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum beta-lactamase. FEMS Microbiol Lett (1997) 2.01
Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. Antimicrob Agents Chemother (1990) 1.96
[Antibiogram Committee of the French Microbiology Society. Report 2000-2001]. Pathol Biol (Paris) (2000) 1.94
Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase. Eur J Clin Microbiol Infect Dis (1991) 1.91
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob Agents Chemother (1998) 1.85
Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. Eur J Clin Microbiol Infect Dis (1990) 1.82
Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol Lett (2001) 1.82
Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance. Antimicrob Agents Chemother (1990) 1.75
Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins. J Antimicrob Chemother (1988) 1.58
Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom. J Antimicrob Chemother (1990) 1.57
Nosocomial infections by chlorhexidine solution contaminated with Pseudomonas pickettii (Biovar VA-I). J Infect (1983) 1.55
Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca. Antimicrob Agents Chemother (1995) 1.53
Characterization of a beta-lactamase from Clostridium clostridioforme. J Antimicrob Chemother (1994) 1.47
Beta-lactamases produced by a Pseudomonas aeruginosa strain highly resistant to carbenicillin. Antimicrob Agents Chemother (1977) 1.47
beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrob Agents Chemother (1996) 1.47
Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacae. Antimicrob Agents Chemother (1987) 1.39
Two novel transferable extended-spectrum beta-lactamases from Klebsiella pneumoniae in Tunisia. FEMS Microbiol Lett (1990) 1.37
Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals. Eur J Clin Microbiol Infect Dis (1989) 1.36
Sequences of the genes for the TEM-20, TEM-21, TEM-22, and TEM-29 extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1999) 1.34
Cloning and sequencing of the gene encoding the AmpC beta-lactamase of Morganella morganii. FEMS Microbiol Lett (1997) 1.33
Distribution of beta-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus. J Antimicrob Chemother (1988) 1.33
Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase. Antimicrob Agents Chemother (2001) 1.31
Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) Blood (1990) 1.30
Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase. FEMS Microbiol Lett (1994) 1.30
[Distribution of constituent beta-lactamases in Pseudomonas aeruginosa]. Presse Med (1984) 1.30
Sugars and flowering in the grapevine (Vitis vinifera L.). J Exp Bot (2008) 1.30
Growth of Yersinia pseudotuberculosis in mouse spleen despite loss of a virulence plasmid of mol. wt 47 X 10(6). J Med Microbiol (1984) 1.29
Silencing and reactivation of urease in Yersinia pestis is determined by one G residue at a specific position in the ureD gene. Infect Immun (2001) 1.29
Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis. Gut (2009) 1.28
Molecular typing of nosocomial isolates of Legionella pneumophila serogroup 3. J Clin Microbiol (1990) 1.27
[Identification of plasmid-encoded cephalosporinase ACC-1 among various enterobacteria (Klebsiella pneumoniae, Proteus mirabilis, Salmonella) isolated from a Tunisian hospital (Sfax 997-2000)]. Pathol Biol (Paris) (2002) 1.26
Immunological comparison of constitutive beta-lactamases of gram-negative bacteria by neutralization in zymogram gels: properties of anti-TEM-1 and anti-TEM-2 sera. Ann Inst Pasteur Microbiol (1988) 1.24
Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status. J Clin Microbiol (1999) 1.22
Pectin secretion and distribution in the anther during pollen development in Lilium. Planta (2001) 1.21
Molecular characterization of IS1541 insertions in the genome of Yersinia pestis. J Bacteriol (1998) 1.18
Two variants of transferrable extended-spectrum TEM-beta-lactamase successively isolated from a clinical Escherichia coli isolate. FEMS Microbiol Lett (1992) 1.18
[Enzymatic constants (Km and Vmax) of beta-lactamases, measured by a computerized micro-acidimetric method]. Ann Microbiol (Paris) (1973) 1.17
[Constitutive cephalosporinases from "Escherichia coli" (author's transl)]. Ann Microbiol (Paris) (1977) 1.17
Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Eur J Immunol (1995) 1.16
Novel transferable extended-spectrum beta-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime. FEMS Microbiol Lett (1991) 1.15
Novel carbenicillin-hydrolyzing beta-lactamase (CARB-5) from Acinetobacter calcoaceticus var. anitratus. FEMS Microbiol Lett (1989) 1.10
Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi. Antimicrob Agents Chemother (2001) 1.09
Genetic environment of acquired bla(ACC-1) beta-lactamase gene in Enterobacteriaceae isolates. Antimicrob Agents Chemother (2006) 1.08
A beta-lactamase-overproducing strain of Alcaligenes denitrificans subsp. xylosoxydans isolated from a case of meningitis. J Antimicrob Chemother (1992) 1.08
Escherichia hermannii: susceptibility pattern to beta-lactams and production of beta-lactamase. J Antimicrob Chemother (1995) 1.06
Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study). Intensive Care Med (1996) 1.06
Two resistance phenotypes to beta-lactams of Alcaligenes denitrificans subsp. xylosoxydans in relation to beta-lactamase types. J Antimicrob Chemother (1990) 1.05
The pmrF polymyxin-resistance operon of Yersinia pseudotuberculosis is upregulated by the PhoP-PhoQ two-component system but not by PmrA-PmrB, and is not required for virulence. Microbiology (2004) 1.03
Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens. J Med Microbiol (1985) 1.02
Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides. Antimicrob Agents Chemother (2000) 1.01
Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis (1996) 1.01
Superantigen bacterial toxins: state of the art. Toxicon (2001) 1.01
Identification of a carbenicillin-hydrolyzing beta-lactamase in Alcaligenes denitrificans subsp. xylosoxydans. Antimicrob Agents Chemother (1995) 1.01
Variations of the analgesia nociception index during general anaesthesia for laparoscopic abdominal surgery. J Clin Monit Comput (2012) 0.99
Plasmid-mediated ROB-1 beta-lactamase in Pasteurella multocida from a human specimen. Antimicrob Agents Chemother (1991) 0.99
Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice. Infect Immun (2000) 0.99
[Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins]. Presse Med (1985) 0.98
Molecular typing of Yersinia pseudotuberculosis by using an IS200-like element. J Clin Microbiol (1996) 0.97
Susceptibility of Alcaligenes denitrificans subspecies xylosoxydans to beta-lactam antibiotics. Eur J Clin Microbiol Infect Dis (1990) 0.96
In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors. J Antimicrob Chemother (1996) 0.96
Describing ancient horizontal gene transfers at the nucleotide and gene levels by comparative pathogenicity island genometrics. Bioinformatics (2005) 0.93
PCR detection of aminoglycoside resistance genes: a rapid molecular typing method for Acinetobacter baumannii. Res Microbiol (1999) 0.93
Phenology of flowering and starch accumulation in grape (Vitis vinifera L.) cuttings and vines. Ann Bot (2005) 0.93
Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins. Antimicrob Agents Chemother (1993) 0.92
Skeletal myogenesis on highly orientated microfibrous polyesterurethane scaffolds. J Biomed Mater Res A (2008) 0.91
[Enzymatic resistance to cefotaxime in 56 strains of Klebsiella spp., Escherichia coli and Salmonella spp. at a Tunisian hospital (1984-1988)]. Pathol Biol (Paris) (1990) 0.91
["Pseudomonas aeruginosa" beta-lactamases and sensitivity to carbenicillin (author's transl)]. Ann Microbiol (Paris) (1976) 0.91
Urease is not involved in the virulence of Yersinia pseudotuberculosis in mice. Infect Immun (1997) 0.90
[Wolff-Parkinson-White syndrome. Evidence of an accessory auriculoventricular tract obtained by recording of the potential of the bundle of His]. Arch Mal Coeur Vaiss (1971) 0.90
His bundle recording and electrical stimulation of atria in patients with Wolff-Parkinson-White syndrome type A. Br Heart J (1972) 0.90
In-vitro uptake of glucose by bovine blastocysts. J Reprod Fertil (1980) 0.90
Association of private isolation rooms with ventilator-associated Acinetobacter baumanii pneumonia in a surgical intensive-care unit. Infect Control Hosp Epidemiol (1997) 0.90
Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases. Drugs (1986) 0.89
[Rifampicin and tetracycline in the treatment of experimental brucellosis in mice]. Ann Inst Pasteur (Paris) (1972) 0.88
Chitosan improves development, and protects Vitis vinifera L. against Botrytis cinerea. Plant Cell Rep (2003) 0.88
[Taxonomic position of the genus Brucella among bacteria isolated from ewes and cows]. Ann Inst Pasteur (Paris) (1969) 0.88